Manager may have sought an edge with his fume after first-leg draw but Champions League semi remains in balance Mikel Arteta has felt the walls closing in on the domestic front in recent weeks. And it was surely a part of the reason why the Arsenal manager went on the offensive about refereeing decisions after his team’s Premier League win over Newcastle on Saturday . Arteta insisted that the Newc...
Manager may have sought an edge with his fume after first-leg draw but Champions League semi remains in balance Mikel Arteta has felt the walls closing in on the domestic front in recent weeks. And it was surely a part of the reason why the Arsenal manager went on the offensive about refereeing decisions after his team’s Premier League win over Newcastle on Saturday . Arteta insisted that the Newcastle goalkeeper, Nick Pope, ought to have been sent off rather than booked for a foul on Viktor Gyökeres, which he argued represented the denial of a goalscoring opportunity. And, while he was at it, Arteta went back to the previous league game – the 2-1 defeat at Manchester City – and made a similar point: he believed the City defender Abdukodir Khusanov should have been dismissed for a last-man foul on Kai Havertz. Continue reading...
The European Central Bank kept interest rates unchanged at 2%, with officials signaling they need more time to assess the extent of the Iran war’s jolt to the economy. The ECB offered no guidance on future decisions, reiterating it will act one meeting at a time based on information as it arrives. Bloomberg's Oliver Crook reports from Frankfurt. (Source: Bloomberg)
The European Central Bank kept interest rates unchanged at 2%, with officials signaling they need more time to assess the extent of the Iran war’s jolt to the economy. The ECB offered no guidance on future decisions, reiterating it will act one meeting at a time based on information as it arrives. Bloomberg's Oliver Crook reports from Frankfurt. (Source: Bloomberg)
NNN REIT press release ( NNN ): Q1 FFO of $0.86 in-line. Revenue of $240.42M (+4.1% Y/Y) beats by $2.03M . Increased ABR by 6.9% over prior-year results to $934.6 million Increased portfolio occupancy to 98.6%, an increase of 30 and 90 basis points over the prior quarter and prior year periods, respectively, with a portfolio weighted average remaining lease term of 10.1 years Additional Highlights...
NNN REIT press release ( NNN ): Q1 FFO of $0.86 in-line. Revenue of $240.42M (+4.1% Y/Y) beats by $2.03M . Increased ABR by 6.9% over prior-year results to $934.6 million Increased portfolio occupancy to 98.6%, an increase of 30 and 90 basis points over the prior quarter and prior year periods, respectively, with a portfolio weighted average remaining lease term of 10.1 years Additional Highlights: Increased AFFO per share guidance to a new range of $3.53 to $3.59 Increased Core FFO per share guidance to a new range of $3.48 to $3.54 vs $3.51 consensus More on NNN REIT NNN REIT: A Reliable Yield To Shield You From An Inflationary World NNN REIT: A Dividend Champion Deal To 'Buy' Now Real Estate Income Is The Wisest Choice In Uncertain Times: NNN Quant ratings uncover top & bottom mid-cap REIT stocks ahead of Q1 earnings Quant check on top retail REIT picks as WSR goes private in $1.7B Ares deal
Galeanu Mihai U.S. Q1 GDP (initial estimate): +2.0% annual rate vs. +2.2% consensus and +0.5% in Q4, according to advance data released by the Bureau of Economic Analysis on Thursday. PCE prices: +4.5% vs. +4.1% consensus and 2.9% prior. Core PCE prices (excluding food and energy): +4.3% vs. +4.1% consensus and 2.7% prior. Developing… Check back for updates. More on the US Economy Jerome Powell to...
Galeanu Mihai U.S. Q1 GDP (initial estimate): +2.0% annual rate vs. +2.2% consensus and +0.5% in Q4, according to advance data released by the Bureau of Economic Analysis on Thursday. PCE prices: +4.5% vs. +4.1% consensus and 2.9% prior. Core PCE prices (excluding food and energy): +4.3% vs. +4.1% consensus and 2.7% prior. Developing… Check back for updates. More on the US Economy Jerome Powell to stay on Fed board for a time after chair term ends: press conference Durable goods rebound more than expected in March on surge in defense orders Middle East Turmoil Fuels Inflation Fears, Testing Fed's Patience April FOMC: Hawks Push Back As Inflation Risks Rise
(RTTNews) - Halozyme Therapeutics, Inc. (HALO) Thursday revealed the appointment of Darren Snellgrove as Chief Financial Officer, effective June 8, 2026.
(RTTNews) - Halozyme Therapeutics, Inc. (HALO) Thursday revealed the appointment of Darren Snellgrove as Chief Financial Officer, effective June 8, 2026.
(RTTNews) - Union Pacific (UNP) and Norfolk Southern (NSC) submitted an amended merger application to the Surface Transportation Board seeking approval to create America's first transcontinental railroad. The deeper analysis confirmed the merger will make rail significantly more
(RTTNews) - Union Pacific (UNP) and Norfolk Southern (NSC) submitted an amended merger application to the Surface Transportation Board seeking approval to create America's first transcontinental railroad. The deeper analysis confirmed the merger will make rail significantly more
Polymarket is partnering with blockchain analytics firm Chainalysis Inc. to help police its platform as prediction markets grapple with increased scrutiny over insider trading. Tools built by Chainalysis for Polymarket’s cryptocurrency-based exchange include a detection model “designed to surface patterns consistent with insider knowledge in prediction markets,” Polymarket said on Thursday. Other ...
Polymarket is partnering with blockchain analytics firm Chainalysis Inc. to help police its platform as prediction markets grapple with increased scrutiny over insider trading. Tools built by Chainalysis for Polymarket’s cryptocurrency-based exchange include a detection model “designed to surface patterns consistent with insider knowledge in prediction markets,” Polymarket said on Thursday. Other tools will produce evidence for law enforcement and regulators, and provide increased protection against cybersecurity threats. Prediction markets allow users to place yes-or-no bets on real-world events, covering everything from elections to sports games. Platforms have faced intense pressure to crack down on insider trading in recent months, after a series of well-timed, profitable bets put a spotlight on the industry. A US soldier this week pleaded not guilty to trading on classified information after prosecutors claimed he made $400,000 from Polymarket bets on the ouster of former Venezuelan leader Nicolas Maduro . Israeli authorities charged two suspects in February with using classified information to place wagers. And in France, officials are investigating suspected tampering with airport weather sensors tied to heavy betting on prediction markets. Read More: Soldier Pleads Not Guilty to Insider Trading on Maduro Raid Every transaction on Polymarket’s primary offshore exchange is logged on a public ledger using blockchain technology, meaning trades are visible to the public and easily traceable . But the platform doesn’t conduct identity checks on its customers, making it easier for savvy users to trade anonymously. This creates a dynamic where eagle-eyed researchers pore over activity records in search of anomalous patterns that might give them a trading edge, and several companies offer tools to copy the bets of those suspected of having insider information. The partnership with Chainalysis will help Polymarket root out trades that pose concerns, according to Neal ...
The post Best Day Trading Platforms in Canada by Ryan Peterson appeared first on Benzinga . Visit Benzinga to get more great content like this. Day trading in Canada requires a platform that combines speed, reliability, and access to the Canadian and U.S. markets. Whether you’re trading stocks listed on the Toronto Stock Exchange (TSX) or the Nasdaq, execution latency and order control are crucial...
The post Best Day Trading Platforms in Canada by Ryan Peterson appeared first on Benzinga . Visit Benzinga to get more great content like this. Day trading in Canada requires a platform that combines speed, reliability, and access to the Canadian and U.S. markets. Whether you’re trading stocks listed on the Toronto Stock Exchange (TSX) or the Nasdaq, execution latency and order control are crucial to maintaining an edge in fast-moving markets. We highlight the five best day trading platforms for Canadian residents, with a focus on tools built for intraday activity. All featured brokers offer Canadian dollar-denominated accounts, meet the nation’s regulatory standards, and provide access to advanced features such as real-time data, direct order routing, and sophisticated risk controls. Table of contents [ Show ] How We Chose the Best Day Trading Platforms in Canada Best Day Trading Platforms in Canada Questrade – Best Overall Plus500 – Best for Multi-Asset Futures Trading Interactive Brokers – Best for Global Market Access CI Direct Trading – Best for Customizable Tools National Bank Direct Brokerage – Best for Low-Cost Equity Trades Wealthsimple – Best for Entry-Level Day Traders Why Execution Speed and Data Access Matter for Canadian Day Traders Choose the Right Fit Frequently Asked Questions How We Chose the Best Day Trading Platforms in Canada We used our methodology adapted specifically to assess brokers serving active Canadian traders. Platforms were evaluated based on: Order execution speed and reliability: Brokers must support low-latency execution, especially during high-volume trading windows. Real-time data and Level II access: We prioritized platforms offering streaming quotes, time & sales, and market depth from Canadian and U.S. exchanges. Margin access and leverage flexibility: Competitive intraday margin rates and clear leverage disclosures were considered essential. Short-selling tools: Availability of hard-to-borrow short shares, locate services, an...
In this article LLY Follow your favorite stocks CREATE FREE ACCOUNT watch now VIDEO 7:29 07:29 Eli Lilly CEO David Ricks on Q1 results, Zepbound-Mounjaro sales growth and launch of Foundayo pill Squawk Box More than 20,000 people have started taking Eli Lilly 's GLP-1 pill Foundayo in its first few weeks on the market, Lilly CEO Dave Ricks told CNBC on Thursday. The FDA approved Lilly's once-daily...
In this article LLY Follow your favorite stocks CREATE FREE ACCOUNT watch now VIDEO 7:29 07:29 Eli Lilly CEO David Ricks on Q1 results, Zepbound-Mounjaro sales growth and launch of Foundayo pill Squawk Box More than 20,000 people have started taking Eli Lilly 's GLP-1 pill Foundayo in its first few weeks on the market, Lilly CEO Dave Ricks told CNBC on Thursday. The FDA approved Lilly's once-daily pill Foundayo earlier this month, making it the second oral GLP-1 drug behind Novo Nordisk's Wegovy pill. Investors have been closely tracking weekly prescriptions for clues on how the launch is going. More than 1,000 people are starting Foundayo a day, Ricks said in an exclusive interview with CNBC. He said it'll take time to build the brand since it's a new drug that doctors and patients don't know. He contrasted it against the launch of the company's Zepbound weight loss injection, which had the same active ingredient as its existing diabetes drug, Mounjaro, and against Novo's Wegovy pill, which had the same brand name and active ingredient as the shot. "So what we're seeing now is basically organic demand, which is pretty strong to us," Ricks said. "This is going to play out over quarters, not days, and I just ask people to take a beat and let us execute," Ricks said. "I think it's going to be just fine." More than 80% of people taking Foundayo are new to GLP-1s, he said. Ricks spoke to CNBC after Eli Lilly posted first-quarter earnings and revenue that easily beat expectations. Due to the timing of the launch, Foundayo was not included in the results. During the quarter, sales of Mounjaro and Zepbound spiked 125% and 80%, respectively. Eli Lilly is trying to maintain its dominance in the GLP-1 market following the successful launch of Novo Nordisk's oral drug. It held a 60.1% share of the U.S. obesity and diabetes drug market in the first quarter, versus 39.4% for Novo Nordisk, according to an earnings presentation. Choose CNBC as your preferred source on Google and n...